vTv Therapeutics Inc.
VTVT
Price:
$27.37
Market Cap:
$71.63M
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases and psoriasis. It is also involved in the clinical development of other programs, including TTP273, an oral small molecule GLP-1 receptor agonist for postprandial glucose excursion to treat cystic fibrosis related diabetes; HPP3033, a non-electrophilic therapeutic approac...[Read more]
Industry
Biotechnology
IPO Date
2015-07-30
Stock Exchange
NASDAQ
Ticker
VTVT
PE Ratio
[-8.29]
ROE
[-206.45%]
Current Ratio
[4.98]
Dividend Yield
[0%]
Enterprise Value
[45.79M]
Dividend History
The ROE as of December 2025 (TTM) for vTv Therapeutics Inc. (VTVT) is -206.45%
According to vTv Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -206.45%. This represents a change of 139.46% compared to the average of -86.21% of the last 4 quarters.
vTv Therapeutics Inc. (VTVT) Historical ROE (quarterly & annually)
How has VTVT ROE performed in the past?
The mean historical ROE of vTv Therapeutics Inc. over the last ten years is 37.13%. The current -206.45% ROE has changed -655.97% with respect to the historical average. Over the past ten years (40 quarters), VTVT's ROE was at its highest in in the March 2022 quarter at 116.45%. The ROE was at its lowest in in the June 2025 quarter at -218.90%.
Average
37.13%
Median
26.62%
Minimum
-151.34%
Maximum
178.44%
vTv Therapeutics Inc. (VTVT) ROE by Quarter and Year
Discovering the peaks and valleys of vTv Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.16%
Maximum Annual ROE = 178.44%
Minimum Annual Increase = -284.45%
Minimum Annual ROE = -151.34%
| Year | ROE | Change |
|---|---|---|
| 2024 | -151.34% | -284.45% |
| 2023 | 82.05% | -54.02% |
| 2022 | 178.44% | 33.82% |
| 2021 | 133.34% | 1.16% |
| 2020 | 10.61% | -76.29% |
| 2019 | 44.75% | 368.68% |
| 2018 | 9.55% | -10.66% |
| 2017 | 10.69% | -40.56% |
| 2016 | 17.98% | -49.02% |
| 2015 | 35.27% | 387.29% |
vTv Therapeutics Inc. (VTVT) Average ROE
How has VTVT ROE performed in the past?
The current ROE of vTv Therapeutics Inc. (VTVT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
36.38%
5-year avg
50.62%
10-year avg
37.13%
vTv Therapeutics Inc. (VTVT) ROE vs. Peers
How is VTVT’s ROE compared to its peers?
vTv Therapeutics Inc.’s ROE is less than MiNK Therapeutics, Inc. (34.02%), greater than CervoMed Inc. (-59.15%), less than Fortress Biotech, Inc. (19.24%), greater than Werewolf Therapeutics, Inc. (-144.40%), greater than OS Therapies Incorporated (-3997.47%), greater than IO Biotech, Inc. (-465.36%), greater than Spruce Biosciences, Inc. (-177.45%), less than NRx Pharmaceuticals, Inc. (138.71%), less than Outlook Therapeutics, Inc. (90.02%), greater than Gain Therapeutics, Inc. (-289.11%),
| Company | ROE | Market cap |
|---|---|---|
| 34.02% | $57.97M | |
| -59.15% | $83.83M | |
| 19.24% | $85.35M | |
| -144.40% | $48.35M | |
| -3997.47% | $64.09M | |
| -465.36% | $48.79M | |
| -177.45% | $52.49M | |
| 138.71% | $42.18M | |
| 90.02% | $91.50M | |
| -289.11% | $126.33M |
Build a custom stock screener for vTv Therapeutics Inc. (VTVT) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like vTv Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
vTv Therapeutics Inc. (VTVT) and other stocks custom spreadsheet templates
The easiest way to analyze a company like vTv Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is vTv Therapeutics Inc.'s ROE?
How is the ROE calculated for vTv Therapeutics Inc. (VTVT)?
What is the highest ROE for vTv Therapeutics Inc. (VTVT)?
What is the 3-year average ROE for vTv Therapeutics Inc. (VTVT)?
What is the 5-year average ROE for vTv Therapeutics Inc. (VTVT)?
How does the current ROE for vTv Therapeutics Inc. (VTVT) compare to its historical average?